March 4 (Reuters) - Maravai LifeSciences Holdings Inc MRVI.O:
MARAVAI LIFESCIENCES HOLDINGS INC -FILES FOR NON- TIMELY 10-K WITH THE U.S. SEC
MARAVAI LIFESCIENCES HOLDINGS-NEEDS ADDITIONAL TIME TO COMPLETE GOODWILL IMPAIRMENT AND INVENTORY ASSESSMENT
MARAVAI LIFESCIENCES HOLDINGS-NON-CASH GOODWILL IMPAIRMENT CHARGE OF ABOUT $12 MILLION IS EXPECTED TO BE RECORDED FOR Q4 2024
MARAVAI LIFESCIENCES HOLDINGS: IDENTIFIED ERROR IN YEAR-END FINANCIAL CLOSE PROCESS WITH RESPECT TO REVENUE RECOGNITION ASSOCIATED WITH SINGLE SHIPMENT
Further company coverage: MRVI.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.